Observational Study
Copyright ©The Author(s) 2023.
World J Nephrol. Dec 25, 2023; 12(5): 168-181
Published online Dec 25, 2023. doi: 10.5527/wjn.v12.i5.168
Figure 1
Figure 1 Kaplan-Meier analysis demonstrated associations between the prescription of three or more antihypertensive agents and all-cause mortality (log-rank, P < 0. 001).
Figure 2
Figure 2 Kaplan-Meier analysis demonstrated associations between the prescription of three or more antihypertensive agents and renal replacement therapy free survival (log-rank, P < 0. 001). RRT: Renal replacement therapy.
Figure 3
Figure 3 Kaplan-Meier analysis demonstrated associations between being prescribed renin angiotensin system blocker at baseline and all-cause mortality (log-rank, P < 0. 001). RAS: Renin angiotensin system.
Figure 4
Figure 4 Kaplan-Meier analysis demonstrated associations between being prescribed renin angiotensin system blocker at baseline and renal replacement therapy free survival (log-rank, P = 0. 136). RAS: Renin angiotensin system.